NCT06239350 Young Adult Tobacco/Nicotine and Cannabis Co-use
| NCT ID | NCT06239350 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Tobacco Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2024-05-13 |
| Primary Completion | 2027-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2024-05-13 with a primary completion date of 2027-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this project is to better understand the relationship between tobacco/nicotine and cannabis using behavioral economics during a tobacco/nicotine quit attempt. All participants will receive tobacco/nicotine cessation treatment (smoking and/or vaping treatment) for 12 weeks. To qualify, participants must be between the ages of 18-25 and use tobacco products (smoke cigarettes and/or vape nicotine) and use cannabis (in any form). Participants do not need to be interested in quitting cannabis/marijuana to qualify. This study is being conducted by the Medical University of South Carolina. All procedures are conducted remotely and there is no in-person visits are needed.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18 and 25 years old * Must use at least one nicotine or tobacco product (nicotine vaping and/or cigarettes) on at least 20 out of the past 30 days for at least the past 3 months * Must express interest in nicotine cessation (all products) * Must submit a positive instant-read, oral fluid cotinine sample prior to enrollment * Must report use of cannabis on at least 10 out of the past 30 days * Must submit a positive instant-read cannabinoid test prior to enrollment * Must be able to provide informed consent Exclusion Criteria: * Any significant or acutely unstable medical, psychiatric, or substance use problem that would contraindicate research, interfere with safety, compromise data integrity, or preclude consistent study participation * Pregnant (self-report) or trying to become pregnant * Self-reported use of medications with smoking cessation efficacy * Immediate interest in cannabis cessation or treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06239350 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Tobacco Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06239350 currently recruiting?
Yes, NCT06239350 is actively recruiting participants. Contact the research team at chapmanb@musc.edu for enrollment information.
Where is the NCT06239350 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06239350 clinical trial?
NCT06239350 is sponsored by Medical University of South Carolina. The trial plans to enroll 350 participants.